logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Danicopan CAS 1903768-17-1

Danicopan CAS 1903768-17-1

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 1903768-17-1

Payment & Shipping Terms

Minimum Order Quantity: negotiation

Price: negotiation

Packaging Details: bag;Drum

Delivery Time: 7-15 days

Payment Terms: T/T, D/A, L/C, Western Union

Supply Ability: KG

Get Best Price
Highlight:
CAS NO::
1903768-17-1
Appearance::
White To Off-white Powder
Molecular Formula::
C26H23BrFN7O3
Molecular Weight::
580.41
EINECS NO::
968-712-2
MDL NO::
MFCD32669786
CAS NO::
1903768-17-1
Appearance::
White To Off-white Powder
Molecular Formula::
C26H23BrFN7O3
Molecular Weight::
580.41
EINECS NO::
968-712-2
MDL NO::
MFCD32669786
Danicopan CAS 1903768-17-1

Product Description:

Product Name: Danicopan CAS 1903768-17-1

 

Synonyms:

Danicopan free base;

(2S,4R)-1-(2-(3-Acetyl-5-(2-methylpyrimidin-5-yl)-1H-indazol-1-yl)acetyl)-N-(6-bromopyridin-2-yl)-4-fluoropyrrolidine-2-carboxamide;

 

 

Chemical & Physical Properties:

Appearance: white to off-white powder

Assay: ≥ 98.0%

Boiling Point: 847.1℃

Density: 1.61g/cm3

Solubility: DMSO:175.0(Max Conc. mg/mL);301.51(Max Conc. mM)

 

Uses

Danicapan (ACH-4471, ACH-0144471, ACH-CFDIS, ALXN 2040) is an effective and selective oral inhibitor of factor D, with a Kd value of 0.54 nM for human factor D. Danicapan can inhibit the activity of alternative pathway of complement (APC) and has the potential to block the complement pathway in paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.